INDmoney review

INDmoney lists LSE-traded UCITS ETFs across ~20 categories — Global Exposure (MSCI World / ACWI / All-World benchmarks), S&P 500, Nasdaq 100, Emerging Markets, Gold, Japan, Technology and more. Its compare table shows ticker, price, AUM and expense ratio per fund, with accumulating classes and USD trading lines. Source: https://www.indmoney.com/ucits/global-exposure-etfs (Sep 2026).

A broad all-country fund buys developed + emerging markets in one holding instead of a US-only bet. Practical edges: accumulating classes reinvest income automatically, and you hold Irish-domiciled fund shares rather than direct US securities (the route our taxation guide flags for $60k+ US estate-tax exposure). It does not remove LRS/TCS/forex costs — funding still counts as remittance abroad.

Four to check: (1) market-cap weighting stays US-heavy, so pairing it with an S&P 500 fund doubles up on the same giants; (2) compare expense ratio + tracking difference + physical-vs-synthetic replication, not the headline name — "World" usually means developed-markets only, ACWI/All-World adds emerging markets; (3) a USD quote is not a currency hedge; (4) INDmoney spreads and withdrawal fees still need verifying before large transfers.

Consider it if you want geographic breadth inside the equity part of your portfolio and have checked overlap with existing US + Indian holdings (all-country funds can include Indian stocks). Skip or wait if you already hold heavy US exposure, want cross-asset safety (global stocks still fall together in crises — that needs bonds, not more equity), or the fee stack is unclear. Educational content, not financial advice — confirm tax treatment with a CA.